Komodo Health Unveils New Insights in Early-Onset Colorectal Cancer at White House Cancer Moonshot Forum

Komodo’s Healthcare Map and Technology Platform Are Increasingly Utilized to Close Gaps in Colorectal Cancer Screening; Research Collaboration Under Way With CDC WASHINGTON–(BUSINESS WIRE)–Today, Komodo Health, a leading healthcare technology company, deepens its commitment to the White House Cancer Moonshot Initiative, joining patient advocates, industry innovators, federal policymakers, and public health officials to accelerate progress … [Read more…]

Castle Biosciences to Highlight Clinical Value of Its Skin Cancer Tests at the 2023 American Academy of Dermatology (AAD) Annual Meeting

FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #AAD–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data supporting its portfolio of skin cancer gene expression profile (GEP) tests will be showcased in one late-breaking oral presentation and three ePosters at the 2023 American Academy of Dermatology (AAD) Annual … [Read more…]

Global Medical REIT Inc. Board Declares 2023 First Quarter Common and Preferred Dividends

BETHESDA, Md.–(BUSINESS WIRE)–Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that its Board of Directors (“Board”) has declared the Company’s 2023 first quarter common and … [Read more…]

Olatec Therapeutics Awarded a Grant from The Michael J. Fox Foundation in Collaboration With Medical University of Innsbruck to Evaluate Dapansutrile in Animal Models of Parkinson’s Disease Progression

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a grant from their Therapeutics Pipeline Program to support preclinical research evaluating Olatec Therapeutics’ lead compound, dapansutrile, in Parkinson’s disease (PD) Under this grant Olatec, in collaboration with Dr. Nadia Stefanova (Medical University of Innsbruck), will be studying dapansutrile in both wildtype and transgenic … [Read more…]

KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Advanced Malignant Pleural Mesothelioma

RAHWAY, N.J. & KINGSTON, Ontario–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and the Canadian Cancer Trials Group (CCTG) today announced that the Phase 2/3 CCTG IND.227/KEYNOTE-483 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met its primary endpoint of overall survival (OS) for the first-line treatment … [Read more…]

Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval

ZAVZPRET is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine in adults Expands Pfizer’s migraine portfolio, which includes an oral therapy for both acute and preventive treatment, to further meet the needs of people living with this debilitating disease NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) … [Read more…]

Analogic CEO Tom Ripp to Present on Transforming Aviation Security, Staffing, And Passenger Experience at Passenger Terminal Expo 2023

Discussion Will Share Insights from Deployment of Advanced Aviation Security Technology BOSTON–(BUSINESS WIRE)–Analogic Corporation announced today that Analogic CEO Tom Ripp will co-present at this year’s Passenger Terminal Expo. The presentation is entitled “Transforming Aviation Security, Staffing, and Passenger Experience.” As airports and airlines seek to rebuild post-Covid-19, a redesign of how passengers experience security … [Read more…]

TransPerfect and Its Staff Raise More Than €50,000 for AFANOC

Donations to Help Families Affected by Childhood Cancer NEW YORK & BARCELONA, Spain–(BUSINESS WIRE)–TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced a 2022 fundraising total of more than €52,000 to benefit the Association of Families and Friends of Oncological Children of Catalonia (AFANOC). TransPerfect employee-led fundraisers for AFANOC … [Read more…]

Chimeric Antigen Receptor-Macrophage (CAR-M) Industry Landscape Analysis Report 2023: Key Stakeholders, Technologies, Pipeline, Partnering and Financing – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing” report has been added to ResearchAndMarkets.com’s offering. This report provides you with a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from an industry perspective as of February 2023. CAR-M cell therapy is an … [Read more…]

Autoinjectors Intellectual Property Landscape Report 2023: Patent Filing Trends, Art Search Expressions, Patent Valuation Analysis, Freedom to Operate, Innovations, White Spaces, and Claims Analysis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Autoinjectors: Intellectual Property Landscape, Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis” report has been added to ResearchAndMarkets.com’s offering. This report captures some of the key R&D-related trends and provides competitive intelligence on intellectual … [Read more…]